Medipal Holdings (TSE:7459) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7459 Medipal Holdings Corp TSE:7459
80 GF Score
Price 円2,906.50
GF Value 円2,749.00
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medipal Holdings Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medipal Holdings  (TSE:7459) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medipal Holdings Cyclically Adjusted PS Ratio Related Terms


Medipal Holdings Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings Cyclically Adjusted PS Ratio Chart

Medipal Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.12 0.15 0.15 0.18

Medipal Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.16 0.17 0.18 0.16

TSE:7459 vs MCK, COR, CAH: Cyclically Adjusted PS Ratio Comparison

For the Medical Distribution subindustry, Medipal Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's Cyclically Adjusted PS Ratio falls into.


TSE:7459
80GF Score
Medipal Holdings Corp TSE:7459
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medipal Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medipal Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Medipal Holdings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4833.953/113.6000*113.6000
=4,833.953

Current CPI (Jun. 2026) = 113.6000.

Medipal Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3,350.844 98.000 3,884.244
201612 3,529.339 98.400 4,074.521
201703 3,243.001 98.100 3,755.402
201706 3,446.400 98.500 3,974.731
201709 3,445.572 98.800 3,961.710
201712 3,536.188 99.400 4,041.358
201803 3,148.914 99.200 3,606.014
201806 3,380.717 99.200 3,871.466
201809 3,314.447 99.900 3,768.981
201812 3,560.965 99.700 4,057.429
201903 3,225.990 99.700 3,675.752
201906 3,443.310 99.800 3,919.439
201909 3,597.381 100.100 4,082.542
201912 3,679.442 100.500 4,159.051
202003 3,437.120 100.300 3,892.890
202006 3,560.196 99.900 4,048.431
202009 3,561.066 99.900 4,049.420
202012 3,878.896 99.300 4,437.488
202103 3,462.457 99.900 3,937.288
202106 3,696.961 99.500 4,220.852
202109 3,667.784 100.100 4,162.440
202112 3,872.420 100.100 4,394.674
202203 3,512.193 101.100 3,946.440
202206 3,755.916 101.800 4,191.278
202209 3,811.605 103.100 4,199.790
202212 4,144.458 104.100 4,522.675
202303 3,774.926 104.400 4,107.582
202306 4,146.828 105.200 4,477.944
202309 4,199.537 106.200 4,492.160
202312 4,431.640 106.800 4,713.804
202403 4,017.850 107.200 4,257.722
202406 4,335.806 108.200 4,552.196
202409 4,389.411 108.900 4,578.853
202412 4,724.686 110.700 4,848.458
202503 4,155.590 111.100 4,249.100
202506 4,552.172 111.700 4,629.604
202509 4,618.018 112.000 4,683.990
202512 4,941.858 113.000 4,968.098
202603 4,424.490 112.700 4,459.823
202606 4,833.953 113.600 4,833.953

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medipal Holdings (TSE:7459) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of 円2,906.50 is trading 5.7% above its estimated GF Value™ of 円2,749.00. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for TSE:7459:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円2,749.00 vs. price of 円2,906.50 (5.7% above fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medipal Holdings Business Description

Other Exchanges MEPDF:USAMAHLY:USA
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
80GF Score

Get the complete analysis for TSE:7459

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,906.50
Price
円2,749.00
GF Value